Intervention

ADVAIR DISKUS

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions2

Lead sponsors shown2

Clinical trials

3 shown

Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent AsthmaNCT02175771 · 2014-07-01

A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUSNCT00400608 · 2006-10-01

Study Of Allergic Rhinitis In Patients Who Also Have AsthmaNCT00296491 · 2005-09-01

Common conditions

Asthma2 Persistent Asthma1

Leading sponsors

GlaxoSmithKline2 Teva Branded Pharmaceutical Products R&D, Inc.1

Trial status mix

COMPLETED3

Phase mix

PHASE42

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.